Transient Adrenogenital Syndrome due to Exposure to Danazol in Utero
article
OA: closed
CC0
⤵ 8 in-corpus citations
Abstract
We describe a premature female infant exposed in utero to danazol during the first trimester of pregnancy. She was first observed in the newborn period with marked degree virilization and clinical findings suggestive of salt-losing congenital adrenal hyperplasia. This was supported by the high plasma levels of 17 alpha-hydroxyprogesterone and adrenocorticotropic hormone and low plasma cortisol level. Levels of testosterone, androstenedione, 11-deoxycortisol, and renin were also elevated. An excessive increase in the levels of 17 alpha-hydroxyprogesterone and 11-deoxycortisol to corticotropin administration associated with impaired increase in plasma cortisol level strongly suggests a partial block in the 21-hydroxylation of 17 alpha-hydroxyprogesterone. However, the high levels of 11-deoxycortisol also suggest a block of the steroid 11 beta-monooxygenase. A year later she was found to have normal basal levels of the adrenal steroids and normal response to corticotropin administration, pointing out the transitory nature of these abnormalities. It may be hypothesized that danazol produced a transitory block of the steroid 21- and 11 beta-monooxygenases in this child.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- Clinical Studies with an Antigonadotropin-Danazol via openalex
- Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis via openalex
- Danazol binding and translocation of steroid receptors via openalex
- Danazol Binding to Rat Androgen, Glucocorticoid, Progesterone, and Estrogen Receptors: Correlation With Biologic Activity via openalex
- Danazol inhibits human adrenal 21-and 11β-hydroxylation invitro via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Danazol Inhibits Steroidogenesis in the Rat Testis<i>in Vitro</i> via openalex
- Danazol May Cause Female Pseudohermaphroditism via openalex
- Danazol therapy in gynaecomastia; recent experience and indications for therapy. via openalex
- Endocrine effects of danazol in menstruating women. via openalex
- Inhibition of Adrenal Steroidogenesis by Danazol in Vivo via openalex
- Pituitary and Testicular Function Studies. I. Experience with a New Gonadal Inhibitor, 17α-Pregn-4-en-20-yno-(2,3-d) isoxazol-17-ol (Danazol)<sup>1</sup> via openalex
- Pituitary Gonadotropin Inhibitory Activity of Danazol via openalex
- The absorption, distribution and metabolic fate of danazol in rats, monkeys and human volunteers. via openalex
- The effect of danazol in sexual precocity. via openalex
- The effect of danazol in the treatment of chronic cystic mastitis. via openalex
- doi:10.1016/0009-8981(72)90421-4 via openalex
- doi:10.1016/s0001-2998(75)80033-x via openalex
- doi:10.1136/pgmj.55.640.71 via openalex
- doi:10.1056/nejm197612232952602 via openalex
Cited by (8)
- Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis 1998
- In utero virilization by danazol: Effects on adrenal steroidogenesis 1995
- Ambiguedad sexual por exposición a DANAZOL 1992
- The effects of fetal exposure to danazol 1992
- A New Therapy for Pelvic Endometriosis and Uterine Adenomyosis: Local Effect of Vaginal and Intrauterine Danazol Application 1990
- Danazol and fetal masculinization: a warning 1985
- Danazol and urogenital sinus formation in pregnancy 1985
- Efficacy and safety of low-dose 15-methyl prostaglandin F2α for cervical ripening in the first trimester of pregnancy 1984
Source provenance
- openalex
- last seen: 2026-05-10T10:16:43.255326+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0
· commercial use OK